Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CMV gB Vaccine in Postpartum Women
NCT00125502Phase 2Completed
- Start
- Aug 1999
- Primary completion
- Jun 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cytomegalovirus infection (CMV) comparing CMV gB Vaccine with Placebo (2 arms). Primary endpoint: Time to CMV infection. Started Aug 1999; status: completed.
02
Drugs
cytomegalovirus subunit vaccine glycoprotein B
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT00125502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00125502.